Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Zastrzyk życia
  • Obniżka
New Developments in Myeloma, An Issue of Hematology/Oncology Clinics of North America

New Developments in Myeloma, An Issue of Hematology/Oncology Clinics of North America

9780443130779
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 4-6 WEEKS
468,67 zł
398,37 zł Zniżka 70,30 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 411,22 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DHL, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
In this issue of Hematology/Oncology Clinics, guest editor Dr. P. Leif Bergsagel brings his considerable expertise to the topic of New Developments in Myeloma. With the advent of next generation sequencing and immune profiling technologies, marked advances have been made recently in the understanding of the molecular and immune pathogenesis of multiple myeloma. Yet even with these advances, there is a continual search for new therapeutic approaches. In this issue, top experts discuss a full range of clinically relevant topics in this complex and fast-changing field.
Szczegóły produktu
Elsevier
100251
9780443130779
9780443130779

Opis

Rok wydania
2024
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Wymiary (mm)
152 x 229
Waga (g)
620
  • Molecular Pathogenesis of Multiple Myeloma: Clinical Implications
    Immune-Pathogenesis of Myeloma
    Smoldering Multiple Myeloma: Observation Versus Control Versus Cure
    Cereblon-targeting ligase degraders in myeloma: Mechanisms of action and resistance
    Proteasome Inhibitors in Multiple Myeloma: Biological Insights on Mechanisms of Action or Resistance Informed by Functional Genomics
    Monoclonal Antibodies in the Treatment of Multiple Myeloma
    Bispecific Antibodies in the Treatment of Multiple Myeloma
    Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma
    Is There Still a Role for Stem Cell Transplantation in Multiple Myeloma?
    Role of Consolidation and Maintenance
    Management of Newly Diagnosed Multiple Myeloma Today, and in the Future
    Impact of Clonal Heterogeneity in Multiple Myeloma
    Measurable Residual Disease and Decision-Making in Multiple Myeloma
    Approach to High-Risk Multiple Myeloma
    New Therapies on the Horizon for Relapsed Refractory Multiple Myeloma
    Immunocompetent Mouse Models of Multiple Myeloma: Therapeutic Implications
Komentarze (0)
Ostatnio przeglądane

  • Często kupowane razem

    Brak dostępnych produktów